Tracking Dissemination and Implementation 

Tracking Dissemination and Implementation 

Throughout 2021, the ACS National Consortium for Cancer Screening and Care collaborated to develop actionable recommendations to accelerate our responses to long-standing and emerging barriers to cancer screening and care. If adopted widely, these recommendations will minimize the detrimental effects of the COVID-19 pandemic and move us forward in prioritizing cancer screening and care as a nation.

We know that ACS staff will play a pivotal role in disseminating, promoting, and implementing the consensus recommendations with state-based and health system partners. Please track your progress and share your successes with us below.  Thank you!

Track Your Dissemination

Please use this form to help us track dissemination as you promote the Consensus Recommendations with your state-based and health system partners.

Share Your Wins

Please use this form to share how you and/or your state-based and health system partners are successfully implementing one or more of the Consensus Recommendations.

© Copyright 2021 American Cancer Society, Inc. | Back to top ↑

The ACS’s enterprise-wide screening initiative, of which the National Consortium is a core component, is supported by generous sponsors including founding sponsor, Genentech, a member of the Roche Group alongside National Football League, Merck (known as MSD outside the United States and Canada), Novartis Oncology, Pfizer Oncology, BD (Becton, Dickinson and Company), Bristol-Myers Squibb, Intuitive, McKesson, AmerisourceBergen, Amgen, Roche Diagnostics and Regeneron/Sanofi-Genzyme.